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Abstract
Background: Shared Decision Making (SDM) is a way to empower patients when decisions are made about
treatment. In order to be effective agents in this process, patients need access to information of good quality.
Routine Outcome Monitoring (ROM) may provide such information and therefore may be a key element in SDM.
This trial tests the effectiveness of SDM using ROM, primarily aiming to diminish decisional conflict of the patient
while making decisions about treatment. The degree of decisional conflict, the primary outcome of this study,
encompasses personal certainty about choosing an appropriate treatment, information about options, clarification
of patient values, support from others and patients experience of an effective decision making process. Secondary
outcomes of the study focus on the working alliance between patient and clinician, adherence to treatment, and
clinical outcome and quality of life.
Methods/Design: This article presents the study protocol of a multi-centre two-arm cluster randomised controlled
trial (RCT). The research is conducted in Dutch specialised mental health care teams participating in the ROM
Quality Improvement Collaborative (QIC), which aims to implement ROM in daily clinical practice. In the
intervention teams, ROM is used as a source of information during the SDM process between the patient
and clinician. Control teams receive no specific SDM or ROM instructions and apply decision making as usual.
Randomisation is conducted at the level of the participating teams within the mental health organisations.
A total of 12 teams from 4 organisations and 364 patients participate in the study. Prior to data collection,
the intervention teams are trained to use ROM during the SDM process. Data collection will be at baseline,
and at 3 and 6 months after inclusion of the patient. Control teams will implement the SDM and ROM model
after completion of the study.
Discussion: This study will provide useful information about the effectiveness of ROM within a SDM framework.
Furthermore, with practical guidelines this study may contribute to the implementation of SDM using ROM in
mental health care. Reporting of the results is expected from December 2016 onwards.
Trial registration: Dutch trial register: TC5262
Trial registration date: 24th of June 2015
Keywords: Routine Outcome Monitoring, Shared Decision Making, Quality Improvement Collaborative (QIC),
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Background
Shared Decision Making (SDM) is defined as an ap-
proach where clinicians and patients share the best
available information when making clinical decisions,
and where patients are supported to consider options to
achieve informed preferences [1]. An important principle
of Shared Decision Making is that there are at least two
experts: the patient and the clinician. The process of SDM
bridges both expert domains [2, 3]. SDM is seen as an
intermediate stage between two extremes a traditional pa-
ternalistic and an informed choice model. In SDM the
clinician and patient deliberate about treatment options
and preferences. They select together the best suitable
option which is consistent with patients’ values and prefer-
ences [2, 4, 5]. Elwyn et al. [1] describe three steps of
SDM: 1) making sure that patients know that reasonable
options are available 2) providing detailed information
about these options, and 3) supporting the consideration
of preferences and decision making about what will be the
best choice.
A few studies testing SDM have been conducted in
mental health care [2, 6], including a small number of
randomised controlled trials and other types of studies,
mostly focusing on psychosis and depression. They in-
dicate that SDM contributes to better informed pa-
tients regarding the disease and treatment options.
Furthermore, it stimulates patients to take an active
part in decisions on treatment options. Also, SDM can
have a positive influence on patient satisfaction, better
acceptance of the agreed treatment, adherence to treat-
ment and reduction of uncertainty by the patient about
the decision taken [2, 7–13]. Finally, SDM increases the
likelihood that treatment is delivered in accordance
with guidelines. Few studies that tested this have found
limited effects of SDM on reduction of symptoms [7, 9],
mainly by the mediating variable treatment adherence
on clinical outcome [9]. Despite the limited but prom-
ising results of SDM widespread implementation seems
to be lagging behind [2, 14–16], while generally pa-
tients prefer greater participation than they are offered
[13, 17, 18]. Patients with severe mental illness and de-
pression have positive attitudes towards SDM, desire to
be involved in decisions, and are also able to participate
in decision making [10, 19–21].
ROM implies regular measurement of clinical out-
comes aiming to improve quality of care. ROM provides
clinical feedback as to the effectiveness of care for patients
and clinicians which may be used to choose appropriate
treatment options [22–27].
In a review Carlier et al. [28] found that feedback with
ROM has positive effects on the behaviour of profes-
sionals with respect to faster and more appropriately
screening to establish the correct diagnosis, more fre-
quent and effective communication between patient
and clinician, and, when appropriate, swifter adjust-
ment of treatment. ROM appears to have a positive
short term effect on mental health status [29] and, if
ROM feedback was used in consultations, is especially
beneficial for the monitoring of patients who are not
responding to treatment, the so called Not-On-Track
(NOT) patients [22, 23, 29–32]. The greatest reduc-
tion of symptoms takes place in the condition where
both parties, patients and clinicians, were provided
with feedback [22, 23]. Measuring outcome of patients
on a regular basis during treatment will allow clinicians to
identify non-responding and negatively responding pa-
tients before they leave their treatment. The sooner a
clinician can be notified that a patient’s positive outcome
is threatened, the sooner preventive actions can be
attempted [33].
Rationale
Both SDM and ROM are able to empower the patient
during the treatment process and to provide good qual-
ity information in order to be a more effective agent in
the decision making process. Such an approach was
evaluated in an open pilot in a centre for patients with
combined physical and mental disorders. The SDM ap-
proach during intake and treatment was combined with
frequent ROM. In line with treatment goals, clinician
and patient choose symptoms to be monitored with
ROM during treatment. The progress in treatment is
evaluated with six weekly monitoring used in a feedback
cycle. This approach proves feasible, adherence of both
patients and professionals is high and patients improve
at symptom level. However, so far, a RCT evaluating
such a combined SDM-ROM approach has not yet been
performed [34]. The expectation is that systematically
sharing the feedback about treatment progress derived
from ROM within a SDM framework may help to em-
power patients, improve their involvement in clinical
decision making and thereby enhance the quality of care.
The SDM-ROM model should be applicable to different
subgroups in mental health care.
Aim and hypotheses
Our aim is to test whether the appliance of a model in
which ROM and SDM are integrated is effective com-
pared to decision making as usual where SDM using
ROM is not implemented.
The first hypothesis is that the combined SDM-ROM
model will lead to less decisional conflict experienced by
patients which encompasses more personal certainty
about choosing an appropriate treatment, good informa-
tion about options, clarification of values, support from
others and experience of an effective decision making
process. Second hypothesis is that the application of the
SDM-ROM model will improve the working relationship
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between patient and clinician, will increase patient’s ad-
herence to treatment and will have positive effects on
clinical outcome and quality of life.
Methods/Design
Trial design
The study is designed as a multi-centre two-arm cluster
randomised controlled trial of Shared Decision Making
(SDM) in specialised mental health care using Routine
Outcome Monitoring (ROM) as a source of information.
A cluster randomised design in which the unit of ran-
domisation is the treatment team is deemed necessary to
prevent spill-over effects between intervention and con-
trol groups. During recruitment of teams for the study,
pairs of teams from the same mental health organisation
are randomly assigned to either the experimental or con-
trol conditions (matched pairs). Control teams will im-
plement the SDM and ROM model after the completion
of the study.
Participants and setting
The study takes place in specialised mental health care
organisations. Due to the expected generic applicability
of the SDM-ROM model, the model is being tested to
various subgroups with the following characteristics: age
(adolescents, adults and elderly patients), diagnosis
(psychotic, common mental and personality disorders)
and setting (outpatient, day-clinic and clinic). In this
study, a total of six intervention and six control teams
from four organisations participate. In accordance to the
sample size calculation (ref. section sample size) the
teams will include 364 patients (182 in the intervention
group and 182 in the control condition, with an average
of 31 patients per team). Patients who don’t speak and
read Dutch are excluded from the study.
Randomisation and blinding
The matched teams treat a similar population of patients,
in a similar geographic catchment area in the Netherlands
and have similar personnel. Randomisation of the teams is
conducted through an independent data manager. Due to
the randomisation at the team level and the nature of the
intervention, blinding of the clinicians and patients is not
possible. To avoid bias due to lack of blinding outcome
parameters will be collected, independent of the research
team, with self-report instruments to be completed both
by patients and clinicians.
Intervention
The intervention teams implement the SDM-ROM model
with five steps (Table 1) both in the intake and treatment
process.
In order to ensure that the use of ROM by clinician and
patient has added value in treatment, the intervention
teams measure with appropriate questionnaires or rating
scales at suitable moments minimal at the beginning,
during and at the end of treatment. The type of ROM-
instruments and frequency of measuring is not centrally
prescribed, but in each intervention team tailored to the
patient group. The appliance of the five steps SDM-ROM
model is the key intervention. To implement the SDM-
ROM model, the intervention teams follow a Quality Im-
provement Collaborative (QIC) program of 1 year, which
can be considered as a multifaceted implementation strat-
egy [35–37], consisting of a mix of improvement strat-
egies, in which training and coaching in the SDM-ROM
model are important components:
National:
 Three conference days for the intervention teams
for exchange and learning, with the expert team and
advisors from the national collaborative support
organisation (Trimbos-institute, Netherlands
Institute of Mental Health and Addiction, https://
www.trimbos.nl/) present.
 Training and booster sessions for the clinicians
participating in the intervention teams about the
SDM-ROM model.
 A workshop about how to use ROM-instruments.
 A network of multidisciplinary teams.
 Experts providing supervision and advice about
ROM best practices.
 Meetings between local team coordinators for
exchange and learning, with the Trimbos-institute
advisors present.
 Meetings for local patient representatives for
exchange and learning.
Table 1 SDM-ROM model
1. Introduction ➣ Refer to expectations about shared process.
➣ Discuss which role the patient desires in decision
making.
➣ Connect with patient’s wishes and goals. ‘What
does he/she want to achieve in treatment?’
➣ Explain about ROM as an information source.
2. Give meaning
to ROM
➣ Discuss ROM outcomes
➣ Steps:
Identify, Understand, Appreciate, Act.
3. Explore options ➣ Discuss options, advantages and disadvantages,
in a neutral manner.
4. Weigh options ➣ Weigh advantages and disadvantages: ‘What’s for
you important?’
5. Shared
Decision
➣ Can a choice be made?
➣ Select together most appropriate option.
➣ Make follow-up appointments.
Shared Decision Making using Routine Outcome Monitoring as an information
source (Step 1 to 5)
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 A QIC ROM website for exchange of presentations,
publications, best practices and tools.
Local:
 Team visits and telephone contacts with Trimbos-
institute advisors for advice and coaching.
 SMART goal setting, actions and indicators written
in action plans (PDCA) by the local teams. Written
feedback on local action plans by Trimbos-institute
advisors.
 Teams organise meetings at their own location to
work on their improvement plans. The teams plan,
implement, evaluate and adjust their actions to
improve the application of ROM as a tool in SDM
(PDCA-cycle).
 Feedback to the local teams with a general survey
about ROM in daily clinical practice (Trimbos-
institute, 2015).
 Involvement of patient representatives in
improvement teams.
 Active management involvement with the
intervention teams.
Data collection
Procedures
To prevent selection bias, clinicians in both groups invite
all patients, based on date of the first treatment session, to
participate in the study during a period of 6 months. In
long term treatment teams, patients are selected by
chronological order of treatment evaluation date. This
group is also followed for a period of 6 months.
The clinicians of the intervention and control teams
inform their patients about the study and obtain in-
formed consent.
In case a patient is transferred to another clinician
within the intervention team during the course of the
study, the SDM and ROM process is transferred to this
clinician. If the patient is transferred to another team
during the treatment, for example from the intervention
to the control team or vice versa, the patient can no
longer participate in the study.
Data collection is conducted by independent research
assistants outside the participating organisations. Depend-
ing on the frequency of consultations between clinician
and patient using the SDM-ROM model, patients are
completing self-report questionnaires at three times (base-
line = T0, 3 months after baseline = T1, and 6 months
after baseline = T2) or twice (baseline = T0 and 6 months
after baseline = T2). In both frequencies of measurement
the questionnaires for the study are sent after the SDM-
ROM conversation. In addition, clinicians answer ques-
tions at T2 regarding their patients. Patients and clinicians
who participate in the study receive a link by email to
complete the questionnaires. If necessary, 1 week later
they get a reminder by email. After 2 weeks an assistant
phones the patients who have not yet answered the ques-
tions. If patients do not use internet, they receive paper
questionnaires by mail.
Outcome measures
Primary outcome measure The primary outcome
measure (Table 2, Fig. 1) is the degree of decisional con-
flict, a central determinant of decision making, which is
defined as ‘personal uncertainty about which option to
choose’ [38]. This will be measured with the translated
Decisional Conflict Scale (DCS). The DCS is a self-
report questionnaire comprising sixteen questions about
personal perceptions of: a) uncertainty in choosing op-
tions, b) modifiable factors contributing to uncertainty
such as feeling uninformed about alternatives, benefits
and risks, unclarity about personal values and unsup-
ported in decision making, c) effective decision making
such as feeling the choice is informed, values-based,
likely to be implemented and expressing satisfaction
with the choice [39]. Each item is measured on a 5-point
Likert scale (0 = strongly agree to 4 = strongly disagree).
Besides the total score, the DCS has the following five
sub scores: certainty, information, clarification of values,
support or pressure from others and the patient’s per-
ception of the quality of the decision process. To calcu-
late the total and sub scores the item scores will be
summed, divided by the number of items and multiplied
by 25. The scores thus range from 0 (no decisional con-
flict) to 100 (extremely high decisional conflict). By ap-
propriate application of SDM using ROM, decisional
conflict is expected to be lowered. Individuals whose
scores will be higher than 37.5, are considered to be un-
comfortable with the decision and tend to delay it. Scores
lower than 25 will be associated with absence of decisional
conflict. In this study we will examine whether the total
and sub scores at this scale are associated with the imple-
mentation of the SDM-ROM model [38, 39].
The psychometric properties of the scale are acceptable.
Test-retest correlations and Cronbach alpha coefficients
exceed 0.78 (reliability). The scale correlates to related
constructs (knowledge, regret, discontinuance) and dis-
criminates between groups who make and delay decisions
(construct validity). DCS is responsive to change between
different decision supporting interventions. Effect sizes
range from 0.4 to 1.2 for the total scale. The predictive
validity of the DCS is also demonstrated. Finally, the in-
strument is easy to administer [38].
Application of the revised Dutch DCS is not known to
us. For this study the DCS is translated from English
into Dutch by two translators separately, who subse-
quently established a consensus version. The consensus
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version was back translated into English by one inde-
pendent native English translator. The native speaker
and the research team checked and discussed the dis-
crepancies between the original version and the transla-
tion, which resulted in a final Dutch version [40].
Secondary outcome measures
The secondary outcome measures (Table 2, Fig. 1) are
the patient-clinician relationship, patient’s adherence to
treatment, clinical outcome and quality of life. The
patient-clinician relationship will be assessed using the
Dutch version of the Working Alliance Inventory Short
Form (WAI-S) [41–43]. For this study the WAI-S is
chosen, because the questionnaire measures the quality
of the alliance on the basis of three aspects related to
SDM: contact/bond, agreement on goals and agreement
on tasks [43–45]. Besides, the WAI-S has patient and
clinician versions, which are both used in this study. The
questionnaire consists of twelve questions concerning
the agreement about treatment targets and tasks, and
the interpersonal connection between patients and clini-
cians. The WAI-S scores from 1 (rarely or never) to 4
(always). Stinckens et al. [43] report a three factor struc-
ture of the patient version of the instrument: a contact/
bond, a task and a goal component. Tracey et al. [41]
also found evidence for one overall score. Psychometric
qualities of the WAI-S proved to be good [41,43, 46, 47].
The scale correlates with outcome moderately. The per-
spective of the patient and a high score on the task scale
are the strongest predictors for positive outcome [43].
In addition to these outcomes, the influence of the pa-
tients’ commitment to the treatment plan will be investi-
gated. Data about no-show and drop out will be extracted
from the electronic patient record by each team.
Finally, effects of SDM using ROM on treatment re-
sults will be studied with either the Manchester Short
Quality of Live Measurement (MANSA-VN-16) [48] for
long term patients or the Outcome Questionnaire (OQ-
45) [49] for short term patients.
The MANSA-VN-16 is a self-report questionnaire
which measures how satisfied the patient is in each of
the following life domains: living situation, social rela-
tionships, physical health, mental health, safety, financial
situation, work situation and life as a whole. Twelve
Table 2 Primary and secondary outcome parameters
Topic & Instrument Method Patient Patient Patient Clinician Organisation
T0 T1 T2
Primary Outcome Parameter
Patient’s perception of SDM
Patient
Decisional Conflict Scale SR X X X
Secondary Outcome Parameter
Patient-clinician relationship
Patient
Working Alliance Inventory SR X X X
Clinician
Working Alliance Inventory (patient level) SR X (T2)
Additional outcome measures
Compliance
Organization
Drop out (patient level) EPR X (T2)
No-Show (patient level) EPR X (T2)
Symptoms-functioning
Patient
OQ-45 SR X X X
Quality of life
Patient
MANSA-16 SR X X X
SR self-report, EPR Electronical Patient Record
T0 = baseline
T1 = Follow-up +/−3 months after baseline (between 10 and 16 weeks)
T2 = +/−6 months after baseline (between 23 and 29 weeks)
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questions are answered on a 7-point scale (1 = not satis-
fied, 7 = very satisfied) and four items are rated by ‘yes’
or ‘no’. An overall score of subjective quality of life can
be calculated as a mean overall score. A higher score on
the MANSA means a better quality of life. The psycho-
metric properties are satisfactory [50].
De OQ-45 is a self-report scale with 45 items, which
measures symptoms, emotional states, interpersonal rela-
tionships and social role functioning. Each item is mea-
sured on a 5-point Likert scale (0 = never to 4 = almost
always). Scoring is reversed for nine positively formulated
items. The scores of the items are summed. This means a
total score ranging from 0 to 180. Higher scores reveal
reporting of more frequent symptoms, distress, interper-
sonal problems and social dysfunction. Apart from the
total scale, the Dutch OQ-45 has the following four sub-
scales: symptomatic distress, anxiety and somatic distress,
interpersonal relations, social role. Results show that the
psychometric properties of the Dutch OQ were adequate
and similar to the original instrument [51].
Treatment integrity
To check the treatment integrity in the intervention
teams, one structure indicator will be measured and
three process evaluation approaches will be conducted
(Table 3). The structure indicator will report how fre-
quently the primary ROM-instrument is completed.
The process evaluation will indicate the implementation
stage of the SDM-ROM model in the intervention teams.
The following three process scales will be used:
1. Four questions for patients and clinicians, developed
by the research team, about the added value and use
of ROM feedback in the conversation between
patients and clinicians. Patients in the intervention
group will be asked to fill out the four ROM-
questions at T0, T1 and T2. At T2 clinicians will
complete the same questions regarding the
consultations with their patients.
2. The SDM-steps will be measured with the
translated Shared Decision Making-Questionnaire-9
(SDM-Q-9), which has a version for patients and
one for clinicians. Both versions ask the patient and
clinician first to enter the health problem the
consultation was about and which decision was
made. The questionnaire continues with nine items
about the steps in the SDM process, scoring at a
six point scale that ranges from 0 (completely
disagree) to 5 (completely agree). A total score can
be calculated by summing the scores of all items. A
high score indicates more SDM. The SDM-Q-9
shows a high reliability. The available results about
the factorial validity are also positive [51, 52]. The
SDM-Q-9 versions were translated into Dutch by
the research team conform the standards of forward
Fig. 1 Primary and secondary outcome parameters in flow chart
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and backward translations (ref. section primary
outcome measure, [40]). A recent publication about
psychometric testing of a translated Dutch version
of the SDM-Q-9 [53] demonstrated good
acceptance, internal consistency, and acceptable to
good convergent validity of the versions for patients
and physicians. Patients in the intervention group will
be asked to complete the SDM-Q-9 at T0, T1 and T2.
At T2 clinicians will complete the same questions
regarding the consultations with their patients.
3. A general survey for clinicians of the intervention
and control group at three moments in a year about
ROM in daily clinical practice [50]. The survey
consists of one question about the extent of using
ROM in daily practice, with five response categories
from ‘never’ to ‘always’. If a clinician scores ‘never’,
the first question is followed by an open question
about the reason(s) of this. After scoring the other
answers, 23 statements about the implementation of
using ROM will be submitted. The statements have
five response categories, ranging from ‘strongly
disagree’ (score 1) to ‘strongly agree’ (score 5). A
higher score means a better implementation of
ROM in daily practice. The development of the
survey is described in a paper of the Trimbos-
institute, Netherlands Institute of Mental Health and
Addiction [54].
Patients’ characteristics at baseline: moderator and
potential covariates
At baseline the following characteristics of patients
(Table 4) will be collected: socio-demographics (sex, age,
and educational level), diagnosis, length of treatment
and locus of control. Locus of control is measured with
the Mastery Scale [55]. This scale is designed to measure
the degree to which people perceive that they can con-
trol factors that influence their life situation. The scale
has been widely used and translated into multiple lan-
guages. Because no standardized scoring recommenda-
tions were provided, investigators developed their own
scoring protocols and the studies are difficult to com-
pare. The original Pearlin Mastery Scale showed good
construct, predictive validity and internal consistency.
The Dutch version, used in the baseline measurement of
this study, consists of five negatively worded items with
five ordered response categories from 1 (strongly agree)
to 5 (strongly disagree), where 5 indicates the highest
level of self-mastery. A total score can be calculated by
summing the scores of all items (range 5–25). This ver-
sion is also used in NEMESIS-I, a Dutch study of mental
and physical health and wellbeing. The reliability of this
version is good [55].
Sample size
This study is designed to detect a medium effect size of
d = 0.5 on the primary outcome between the interven-
tion and control group. A significance level set at α =
0.05 and 65 patients per arm yield a power of 0.80 [56].
Due to the cluster-randomisation at team level, we will
calculate the effective sample size with an intra cluster
correlation coefficient (ICC). The ICC is a measure of
relatedness of responses within a cluster [57]. When
adjusting for clustering within teams we expect an ICC
= 0.05. Using the following formula [57]: Design Effect
(DE) = 1 + (m-1) ICC (0.05), the sample size needs to be
136 patients per arm. Finally we expect a drop out of
25 %. This requires an initial inclusion of 182 patients
per arm, which means that on average 31 patients per
team per arm, will be included.
Table 3 Treatment integrity check and measuring moments
Topic & Instrument Method Patient Patient Patient Clinician
T0 T1 T2
Treatment Integrity Check
Patient
SDM-Q-9 SR X X X
ROM-questions SR X X X
Clinician
SDM-Q-9 (patient level) SR X (T2)
ROM-questions (patient
level)
SR X (T2)
Survey about ROM in
daily clinical practice.
(clinician level)
SR X (T0,
T1, T2)
T0 = baseline
T1 = Follow-up +/−3 months after baseline (between 10 and 16 weeks)
T2 = +/−6 months after baseline (between 23 and 29 weeks)
Survey ROM in daily practice in intervention and control group
Table 4 Patients’ characteristics
Topic & Instrument Method Patient Clinician Organisation
T0 T0 T0
Patients’ characteristics
at baseline
Patient
Educational level SR X
Locus of Control-Mastery SR X
Organisation
Age EPR X
Sex EPR X
Diagnosis EPR X
Care domain EPR X
Length of treatment EPR X
SR self-report, EPR Electronical Patient Record
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Statistical analyses
The data will be analysed according to the intention-to-
treat principle. In addition, a completer analysis will be
performed. In order to assess whether randomization
resulted in similar groups, differences between the two
arms will be examined on relevant variables (e.g. sex,
age, educational level, diagnosis, length of treatment,
locus of control) using independent samples t-tests for
the continuous variables and Chi-Square tests for the
categorical variables. Variables that are distributed un-
evenly among the two arms will be entered as covari-
ates when testing the effectiveness of the intervention.
The hypotheses will be tested using multivariate linear
regression and, due to the cluster randomisation, multi-
level analyses.
In addition, the patients’ and clinicians’ views on the
ROM-application (ROM questions), Shared Decision Mak-
ing process (SDM-Q-9) and Working Alliance (WAI) will
be compared. If they show different views, the interaction
with the primary and secondary outcome parameters will
be studied.
Analyses will be conducted using SPSS. Reporting of
the results of the study will be in accordance with the
CONSORT statement 2010 (extension cluster rando-
mised trials).
Ethics and trial registration
The Medical Ethics Review Committee of VU University
Medical Centre declared that the Medical Research In-
volving Human Subjects Act (WMO) does not apply to
this study (reference number: 2015.237). An official ap-
proval of this study by our committee is not required.
Patients will be informed of all procedures and asked for
written informed consent. The patients will be informed
that they can withdraw their consent to participate at
any time without specification of reasons and without
negative consequences with regard to future treatment.
This study is registered in the Dutch Trial Register with
number: TC5262, registration date: 24th of June 2015.
Discussion
Although previous results of SDM in mental health care
are promising, few studies have been conducted in this
sector [2, 6]. Integrating systematic clinical feedback de-
rived from ROM within a SDM framework may further
enhance the communication between patient and clin-
ician, empowerment of the patient and lead to better
treatment outcomes. To investigate SDM in mental
health care using ROM, a multi-centre two-arm cluster
randomised controlled trial will be conducted, which hy-
pothesizes positive effects on 1) patient’s perception of
decisional conflict, 2) the working alliance between pa-
tient and clinician, 3) adherence to treatment, and 4)
clinical outcome and quality of life.
Strength of this study is the matched pair design. Due to
randomisation at cluster level between two similar teams
of the same organisation, the risk of confounding is re-
duced. Second, a strong aspect is that the data collection
for this research, with self-report instruments to be com-
pleted both by patients and clinicians, is conducted
through independent research assistants, which dimin-
ishes undesired influence of the research team or clini-
cians on the results. The independent data collection also
reduces the chance of social desirable answers and en-
hances uniformity and quality of the collected data.
The third strength of the study is that at T2, both the
patients and the clinicians of the intervention group are
invited to complete questionnaires about the use of
ROM in the SDM framework. In addition, in both con-
ditions, the working alliance between patient and clin-
ician is examined from both points of view. If there are
different views between patients and clinicians, they will
be detected and further analysed.
Finally, as this study is conducted in real world clinical
practices, the study will have good external validity. By its
broad scope, including various ages, diagnostic groups
and therapeutic settings, the results will be generalizable
to a large group of mental health care teams, clinicians
and patients.
The study has some limitations that could influence
the results. First, the clinicians are not blinded for the
design. It is possible that clinicians, working in the con-
trol teams, make additional efforts to improve SDM
using ROM. In addition, there is a chance that know-
ledge about SDM and ROM from the intervention group
will cross over to the control group. Despite the fixed
composition of the teams, there probably will be changes
in the participating organisations and in the composition
of teams which may affect the study and its findings. If
this is the case the principal investigator will deliberate
with the project manager and the involved clinicians
about the best solution.
If the clinical use of ROM within a SDM framework is
found to be effective, the implementation of both ROM
and SDM in mental health care will be encouraged. Such
a finding will also give the field practical guidance on
how to implement SDM using ROM in the best way,
which may contribute to the empowerment of patients
in mental health care.
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